Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution
This case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how patient engagement in larger corporations can be a long-term growth driver and not just a short-term cost.
Summary:
This podcast from the 2024 DPHARM conference showcases the value of patient engagement as a core strategic investment by focusing on the connection between patient engagement and tangible patient benefits / long-term business sustainability.
The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be done in larger corporations and to emphasize patient engagement as a long-term growth driver and not just a short-term cost.
The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be done in larger corporations and to emphasize patient engagement as a long-term growth driver and not just a short-term cost.
More specifically:
- Protocol design and executional practice, and the impact of current practices on protocol performance
- Framework, process and use cases for optimization of protocol performance through operationalization of patient preferences
- Direct impact on corporate goals like recruitment, retention and growth
For more information, go to DPHARMconference.com.
Related Podcasts
View All
Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution
How Pharma Is Adopting Generative AI Across Clinical Development
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships
